PSY5 A MARKOV MODEL TO ESTIMATE THE EFFECT OF CANAKINUMAB ON THE PROGRESSION OF AA AMYLOIDOSIS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC-FEVER SYNDROMES (CAPS)

Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72954-0
https://www.valueinhealthjournal.com/article/S1098-3015(11)72954-0/fulltext
Title : PSY5 A MARKOV MODEL TO ESTIMATE THE EFFECT OF CANAKINUMAB ON THE PROGRESSION OF AA AMYLOIDOSIS IN PATIENTS WITH CRYOPYRIN-ASSOCIATED PERIODIC-FEVER SYNDROMES (CAPS)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72954-0&doi=10.1016/S1098-3015(11)72954-0
First page : A460
Section Title : RESEARCH POSTER ABSTRACTS
Open access? : No
Section Order : 1112
Categories :
Tags :
Regions :
ViH Article Tags :